Danazol: all 24 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Combination Therapy With Danazol, Prednisolone, and Thalidomide for Thalidomide-Refractory Transfusion-Dependent β-ThalassemiaRecruitingNCT07884773Phase 3
- Repurposed Drugs to Improve Haematological Responses in Myelodysplastic SyndromesRecruitingNCT04997811Phase 2
- Danazol for Treatment of Cytopenias in Patients With CirrhosisRecruitingNCT04873102Phase 2
- Combination of Danazole With Berberine in the Treatment of ITPStatus unknownNCT03909763Phase 2Results posted
- A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.CompletedNCT01821677Phase 2Results posted
- Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With MyelofibrosisCompletedNCT01732445Phase 2Results posted
- Danazol for Genetic Bone Marrow and Lung DisordersCompletedNCT01441037Phase 1/2Results posted
- Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis CongenitaTerminatedNCT01001598Phase 1/2Results posted
- Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)TerminatedNCT00953771Phase 2Results posted
- Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.CompletedNCT04757532Phase 1
- The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary FibrosisTerminatedNCT04638517Phase 2
- The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT04481282Phase 2
- A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With ThrombocytopeniaStatus unknownNCT04324060Phase 2/3
- Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune ThrombocytopeniaStatus unknownNCT04289207Phase 2
- Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to TelomeropathyStatus unknownNCT03710356Phase 1/2
- Effect of Danazol on Endometrial αvβ3 Integrin Expression in Patients With Unexplained Recurrent Implantation FailureCompletedNCT03563664Phase 3
- The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03460808Phase 1/2
- Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing LaparoscopyCompletedNCT03352076Phase 2
- Low-Dose Danazol for the Treatment of Telomere Related DiseasesCompletedNCT03312400Phase 2
- Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular EdemaCompletedNCT02002403Phase 2
- Danazol Treatment in Endometriosis Women Before IVFCompletedNCT01779232Phase 4
- An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic MastalgiaCompletedNCT01105793Phase 2
- A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast DiseaseCompletedNCT00744276Phase 2
- Danazol in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNCT00003946Phase 2